We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ELF Q4 Earnings Surpass Estimates, Net Sales Increase Y/Y
Read MoreHide Full Article
Key Takeaways
ELF delivers 35.1% Q4 sales growth as Rhode contributes $113 million in net sales.
e.l.f. Beauty records its 29th straight quarter of net sales growth across channels.
ELF projects fiscal 2027 sales growth of 12-14% with continued marketing investment.
e.l.f. Beauty, Inc. (ELF - Free Report) posted fourth-quarter fiscal 2026 results, wherein both the top and bottom lines beat estimates. The top line increased year over year, while the adjusted EPS declined compared to the prior-year period.
ELF Q4 Results: Key Metrics & Insights
ELF posted adjusted earnings of 32 cents per share, down 59% from 78 cents a year ago. The figure beat the Zacks Consensus Estimate of 29 cents.
Net sales of $449.3 million rose 35.1% year over year from $332.7 million and surpassed the Zacks Consensus mark of $426 million. The quarter’s sales increase was driven by growth in both retail and e-commerce channels, spanning the United States and international markets.
The company highlighted that Rhode contributed $113 million in net sales during the fiscal fourth quarter, while organic net sales growth for the quarter was 1%.
e.l.f. Beauty’s Margin & Cost Performance
Gross profit increased to $326.5 million, up 37.7% year over year from $237 million. Gross margin improved about 140 basis points year over year to 73% in the fiscal fourth quarter. The company cited pricing benefits as the primary tailwind, while also flagging higher tariffs as a partial offset.
Adjusted selling, general and administrative expenses increased significantly by 73.1% year over year to $300 million from $173.3 million. The increase is primarily due to higher marketing, merchandising and distribution costs, compensation and benefits, depreciation and amortization, professional fees and regulatory fees.
The company reported adjusted EBITDA of $58.8 million, down 27.7% year over year from $81.4 million in the prior-year period. Adjusted EBITDA margin declined to 13% of net sales, indicating pressure on overall profitability during the period.
ELF’s Balance Sheet & Financial Position
Cash and cash equivalents were $289.7 million as of March 31, 2026, while total debt was $841.7 million compared with $148.7 million of cash and $256.7 million of debt a year earlier. The balance sheet expansion reflects the financing and balance-sheet mechanics associated with the Rhode acquisition. Cash generation from operations was $212.5 million for fiscal 2026.
e.l.f. Beauty’s Fiscal 2027 Outlook
The Zacks Rank #3 (Hold) company guided fiscal 2027 net sales in the range of $1,835-$1,865 million, implying expected growth of 12-14% year over year, with expected organic sales growth of 4-5% year over year. The company also projected adjusted EBITDA of $379-$385 million and adjusted net income of $198-$201 million.
The earnings presentation further outlined an expected gross margin level of 71% and a tariff outlook of roughly 35% for fiscal 2027, along with marketing and digital investment targeted at 23-25% of net sales, keeping the focus on balancing growth with margin management.
The company’s shares have lost 43.7% in the past three months compared with the industry’s decline of 32.3%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks have been discussed below:
The Estée Lauder Companies Inc. (EL - Free Report) manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. At present, EL sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for EL’s current fiscal-year sales and earnings indicates growth of 4.5% and 59.6%, respectively, from the year-ago figures. EL delivered a trailing four-quarter earnings surprise of 39.1%, on average.
Nu Skin Enterprises, Inc. (NUS - Free Report) engages in the development and distribution of various beauty and wellness products worldwide. At present, NUS carries a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for NUS’ current fiscal-year sales and earnings implies a decline of 4% and 21.3%, respectively, from the year-ago figures. NUS delivered a trailing four-quarter earnings surprise of 1.1%, on average.
Interparfums, Inc. (IPAR - Free Report) manufactures, markets, and distributes a range of fragrances and fragrance-related products in the United States and internationally. At present, the company holds a Zacks Rank of 2.
The consensus estimate for Interparfums’ current fiscal-year sales and earnings implies a decline of 0.1% and 8%, respectively, from the year-ago figures. IPAR delivered a trailing four-quarter earnings surprise of 8%, on average.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
ELF Q4 Earnings Surpass Estimates, Net Sales Increase Y/Y
Key Takeaways
e.l.f. Beauty, Inc. (ELF - Free Report) posted fourth-quarter fiscal 2026 results, wherein both the top and bottom lines beat estimates. The top line increased year over year, while the adjusted EPS declined compared to the prior-year period.
ELF Q4 Results: Key Metrics & Insights
ELF posted adjusted earnings of 32 cents per share, down 59% from 78 cents a year ago. The figure beat the Zacks Consensus Estimate of 29 cents.
e.l.f. Beauty Price, Consensus and EPS Surprise
e.l.f. Beauty price-consensus-eps-surprise-chart | e.l.f. Beauty Quote
Net sales of $449.3 million rose 35.1% year over year from $332.7 million and surpassed the Zacks Consensus mark of $426 million. The quarter’s sales increase was driven by growth in both retail and e-commerce channels, spanning the United States and international markets.
The company highlighted that Rhode contributed $113 million in net sales during the fiscal fourth quarter, while organic net sales growth for the quarter was 1%.
e.l.f. Beauty’s Margin & Cost Performance
Gross profit increased to $326.5 million, up 37.7% year over year from $237 million. Gross margin improved about 140 basis points year over year to 73% in the fiscal fourth quarter. The company cited pricing benefits as the primary tailwind, while also flagging higher tariffs as a partial offset.
Adjusted selling, general and administrative expenses increased significantly by 73.1% year over year to $300 million from $173.3 million. The increase is primarily due to higher marketing, merchandising and distribution costs, compensation and benefits, depreciation and amortization, professional fees and regulatory fees.
The company reported adjusted EBITDA of $58.8 million, down 27.7% year over year from $81.4 million in the prior-year period. Adjusted EBITDA margin declined to 13% of net sales, indicating pressure on overall profitability during the period.
ELF’s Balance Sheet & Financial Position
Cash and cash equivalents were $289.7 million as of March 31, 2026, while total debt was $841.7 million compared with $148.7 million of cash and $256.7 million of debt a year earlier. The balance sheet expansion reflects the financing and balance-sheet mechanics associated with the Rhode acquisition. Cash generation from operations was $212.5 million for fiscal 2026.
e.l.f. Beauty’s Fiscal 2027 Outlook
The Zacks Rank #3 (Hold) company guided fiscal 2027 net sales in the range of $1,835-$1,865 million, implying expected growth of 12-14% year over year, with expected organic sales growth of 4-5% year over year. The company also projected adjusted EBITDA of $379-$385 million and adjusted net income of $198-$201 million.
The earnings presentation further outlined an expected gross margin level of 71% and a tariff outlook of roughly 35% for fiscal 2027, along with marketing and digital investment targeted at 23-25% of net sales, keeping the focus on balancing growth with margin management.
The company’s shares have lost 43.7% in the past three months compared with the industry’s decline of 32.3%.
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks have been discussed below:
The Estée Lauder Companies Inc. (EL - Free Report) manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. At present, EL sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for EL’s current fiscal-year sales and earnings indicates growth of 4.5% and 59.6%, respectively, from the year-ago figures. EL delivered a trailing four-quarter earnings surprise of 39.1%, on average.
Nu Skin Enterprises, Inc. (NUS - Free Report) engages in the development and distribution of various beauty and wellness products worldwide. At present, NUS carries a Zacks Rank of 2 (Buy).
The Zacks Consensus Estimate for NUS’ current fiscal-year sales and earnings implies a decline of 4% and 21.3%, respectively, from the year-ago figures. NUS delivered a trailing four-quarter earnings surprise of 1.1%, on average.
Interparfums, Inc. (IPAR - Free Report) manufactures, markets, and distributes a range of fragrances and fragrance-related products in the United States and internationally. At present, the company holds a Zacks Rank of 2.
The consensus estimate for Interparfums’ current fiscal-year sales and earnings implies a decline of 0.1% and 8%, respectively, from the year-ago figures. IPAR delivered a trailing four-quarter earnings surprise of 8%, on average.